CS

Chandrima Sinha

Active Director Director DIN 09092701
DIN 09092701 First appointment Mar 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Mar 2021
Shareholding value Locked Premium profile

About Chandrima Sinha

Data last updated:

Chandrima Sinha has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Meditech School Of Healthcare Studies. Engaged in Technology. Contributes to corporate operations.

DIN 09092701
Primary Designation Director
First Appointment 15 Mar 2021
Oldest Company Age 21 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Director15 Mar 20212005Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Meditech School Of Healthcare Studies
Premium access

Shareholding and investment profile for Chandrima Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrima Sinha

Chandrima Sinha has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Meditech School Of Healthcare Studies. Engaged in Technology. Contributes to corporate operations.

Chandrima Sinha is associated with 1 company as Director.

Chandrima Sinha has expertise in Technology.

Chandrima Sinha has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available